# EDGAR Filing Document

**Accession Number:** 0001130781
**File Stem:** 0001477932-25-005846
**Filing Date:** 2025-8
**Character Count:** 59062
**Document Hash:** 6415f83356b8a0e50b479b1b010a61eb
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001477932-25-005846.hdr.sgml**: 20250814

**ACCESSION NUMBER**: 0001477932-25-005846

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 38

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250814

**DATE AS OF CHANGE**: 20250814

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NEURALBASE AI LTD.
- **CENTRAL INDEX KEY:** 0001130781
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MOTION PICTURE & VIDEO TAPE PRODUCTION [7812]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 912090516
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-33325
- **FILM NUMBER:** 251216425

**BUSINESS ADDRESS:**
- **STREET 1:** CALLE 98 NO.19 A - 79 AP
- **STREET 2:** 410 LOCALIDAD DE CHAPINERO
- **CITY:** BOGOTA
- **STATE:** F8
- **ZIP:** 00000
- **BUSINESS PHONE:** 727-314-3717

**MAIL ADDRESS:**
- **STREET 1:** CALLE 98 NO.19 A - 79 AP
- **STREET 2:** 410 LOCALIDAD DE CHAPINERO
- **CITY:** BOGOTA
- **STATE:** F8
- **ZIP:** 00000

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Viratech Corp.
- **DATE OF NAME CHANGE:** 20130123

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Imperia Entertainment, Inc.
- **DATE OF NAME CHANGE:** 20070426

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Soleil Film, Inc.
- **DATE OF NAME CHANGE:** 20041020

?xml version='1.0' encoding='ASCII'? nbbi_10q.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

(Mark One)

☒&nbsp;&nbsp;&nbsp;&nbsp; QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended: **<u>June 30, 2025</u>**

OR

☐&nbsp;&nbsp;&nbsp;&nbsp; TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period From ____________ to ____________.

---

| |
|:---|
| **NEURALBASE AI LTD.** |
| (Exact name of registrant as specified in its charter) |

---

---

| | | |
|:---|:---|:---|
| **Nevada** | **000-33325** | **N/A** |
| (State or other jurisdiction <br>of Incorporation) | (Commission <br>File Number) | (IRS Employer <br>Identification No.) |

---

**10409 Pacific Palisades Ave.**

**<u>Las Vegas, NV 89144-1221</u>**

(Address of principal executive offices, including zip code.)

**<u>(727) 314 3717</u>**

(Telephone number, including area code)

Securities registered under Section 12(b) of the Act: **None**

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒&nbsp;&nbsp;&nbsp;&nbsp; No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒&nbsp;&nbsp;&nbsp;&nbsp; No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer  | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☒ |
|  |  | Emerging growth company | ☒ |

---

If an emerging growth company, indicate by check mark if the Company has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐&nbsp;&nbsp;&nbsp;&nbsp; No ☒

As of August 14, 2025, the registrant had 59,790,183 shares of common stock issued and outstanding.

**NEURALBASE AI LTD.**

 **FORM 10-Q**

Index

---

| | | |
|:---|:---|:---|
| **[PART I. FINANCIAL INFORMATION](#p1)** | **[PART I. FINANCIAL INFORMATION](#p1)** |  |
| [Item 1.](#i1) | [Condensed Financial Statements.](#i1) | 4 |
|  | [CONDENSED BALANCE SHEETS](#bs) | 4 |
|  | [CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)](#op) | 5 |
|  | [CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)](#cf) | 7 |
|  | [CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)](#eq) | 6 |
|  | [NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)](#n) | 8 |
| [Item 2.](#i2) | [Management's Discussion and Analysis of Financial Conditions and Results of Operations.](#i2) | 14 |
| [Item 3.](#i3) | [Quantitative and Qualitative Disclosures about Market Risk.](#i3) | 16 |
| [Item 4.](#i4) | [Controls and Procedures.](#i4) | 16 |
| **[PART II. OTHER INFORMATION](#p2)** | **[PART II. OTHER INFORMATION](#p2)** |  |
| [Item 1.](#ii1) | [Legal Proceedings.](#ii1) | 18 |
| [Item 1A.](#ii1a) | [Risk Factors.](#ii1a) | 18 |
| [Item 2.](#ii2) | [Unregistered Sales of Equity Securities and Use of Proceeds.](#ii2) | 18 |
| [Item 3.](#ii3) | [Defaults Upon Senior Securities.](#ii3) | 18 |
| [Item 4.](#ii4) | [Mine Safety Disclosures.](#ii4) | 18 |
| [Item 5.](#ii5) | [Other Information.](#ii5) | 18 |
| [Item 6.](#sign) | [Exhibits.](#sign) | 19 |

---

---

| |
|:---|
| 2 |
| *[**Table of Contents**](#toc)* |

---

**SPECIAL NOTE REGARDING FORWARD-LOOKING INFORMATION**

This quarterly report on Form 10-Q and other publicly available documents, including the documents incorporated herein by reference, contain, and our officers and representatives may from time to time make, "forward-looking" statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "believe," "expect," "future," "likely," "may," "plan," "seek," "will" and similar references to future periods actions or results. Examples of forward-looking statements include our prospects for one or more future material transactions, potential sources of financing, and expenses for future periods.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements.

Any forward-looking statement made by us in this quarterly report on Form 10-Q is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Factors that could cause or contribute to such differences may include, but are not limited to, those described under the heading *"Risk Factors"* which may be included in the Company's Registration Statement on Form 10 as previously filed with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. The Company undertakes no obligation to revise any forward-looking statements in order to reflect events or circumstances that may subsequently arise. Readers are urged to carefully review and consider the various disclosures made by the Company in this report and in the Company's other reports filed with the Commission that advise interested parties of the risks and factors that may affect the Company's business.

---

| |
|:---|
| 3 |
| *[**Table of Contents**](#toc)* |

---

**PART I. FINANCIAL INFORMATION**

**Item 1. Condensed Financial Statements.**

NEURALBASE AI LTD . AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **June 30,** <br>**2025** | **December 31,** <br>**2024** |
| ASSETS |  |  |
| Current assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash | - | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets |  |  |
| Total assets | - | - |
| LIABILITIES AND STOCKHOLDERS' DEFICIT |  |  |
| Current liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | 200949 | 201628 |
| &nbsp;&nbsp;&nbsp;&nbsp;Advances | 127650 | 127650 |
| Advances - Related party  | 80680 | 80680 |
| &nbsp;&nbsp;&nbsp;&nbsp;Judgement payable | 103000 | 103000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes payable - related party | 7000 | 7000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes payable | 202485 | 143039 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 721764 | 662997 |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes payable, net of debt discount | 46000 | 46000 |
| Total liabilities | 767764 | 708997 |
| Stockholders' deficit |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred stock, $0.0001 par value, 480,000,000 shares authorized, 0 and 0 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Class A Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 9,003,774 and 9,003,774 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 900 | 900 |
| &nbsp;&nbsp;&nbsp;&nbsp;Class B Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 3,500,000 and 3,500,000 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 250 | 350 |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.0001 par value, 2,500,000,000 shares authorized, 200,183 and 200,183 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 5979 | 20 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid in capital | 3345131 | 3255090 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated deficit | (4120024) | (3965357) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' deficit | (767764) | (708997) |
| Total liabilities and stockholders' deficit | - | - |

---

See accompanying notes to the consolidated financial statements

---

| |
|:---|
| 4 |
| *[**Table of Contents**](#toc)* |

---

NEURALBASE AI LTD . AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the three months ended** | **For the three months ended** | **For the six months ended** | **For the six months ended** |
|  | **June 30,** <br>**2025** | **June 30,** <br>**2024** | **June 30,** <br>**2025** | **June 30,** <br>**2024** |
| Revenue | $- | $- | $- | $- |
| Cost of goods sold | - | - | - | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit |  |  |  |  |
| Operating expenses |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 107183 | 4730 | 109621 | 11710 |
| &nbsp;&nbsp;&nbsp;&nbsp;Professional fees | 19500 | 1545 | 33500 | 28045 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 126683 | 6275 | 143121 | 39755 |
| Loss from operations | (126683) | (6275) | (143121) | (39755) |
| Other income (expenses) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (6587) | (3932) | (11546) | (7476) |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on acquisition of intangible assets |  | (720000) |  | (720000) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other income (expenses) | (6587) | (723932) | (11546) | (727476) |
| Net loss before tax provision | (133270) | (730207) | (154667) | (767231) |
| Tax provision | - | - | - | - |
| Net income (loss) | $(133270) | $(730207) | $(154667) | $(767231) |
| Net income (loss) per common share - basic and diluted | $(0.00) | $(3.65) | $(0.00) | $(3.83) |
| Weighted average number of common shares outstanding - basic and diluted | 41589708 | 200183 | 45944824 | 200183 |

---

See accompanying notes to the consolidated financial statements

---

| |
|:---|
| 5 |
| *[**Table of Contents**](#toc)* |

---

NEURALBASE AI LTD . AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

(Unaudited)

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Class A Preferred Stock** | **Class A Preferred Stock** | **Class B Preferred Stock** | **Class B Preferred Stock** | **Common Stock** | **Common Stock** | | | |
|  | **Shares**  | **Amount**  | **Shares**  | **Amount**  | **Shares**  | **Amount**  | **Additional** <br>**Paid-in** <br>**Capital**  | <br>**Accumulated** <br>**Deficit**  | **Total** <br>**Stockholders'** <br>**Deficit**  |
| Balance, December 31, 2024 | 9003774 | 900 | 3500000 | 350 | 200183 | 20 | 3255090 | (3965357) | (708997) |
| Conversion of Class A Preferred Stock to Common stock | (1000000) | (100) |  |  | 50000000 | 5000 | (4900) |  |  |
| Net loss | - | - | - | - | - | - | - | (21397) | (21397) |
| Balance, March 31, 2025 | 8003774 | 800 | 3500000 | 350 | 50200183 | 5020 | 3250190 | (3986754) | (730394) |
| Common shares issued for cash |  |  |  |  | 9590000 | 959 | 94941 |  | 95900 |
| Net loss | - | - | - | - | - | - | - | (133270) | (133270) |
| Balance, June 30, 2025 | 8003774 | 800 | 3500000 | 350 | 59790183 | 5979 | 3345131 | (4120024) | (767764) |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Class A Preferred Stock**  | **Class A Preferred Stock**  | **Class B Preferred Stock**  | **Class B Preferred Stock**  | **Common Stock**  | **Common Stock**  | | | |
|  | **Shares**  | **Amount**  | **Shares**  | **Amount**  | **Shares**  | **Amount**  | **Additional** <br>**Paid-in** <br>**Capital**  | <br>**Accumulated** <br>**Deficit**  | **Total** <br>**Stockholders'** <br>**Deficit**  |
| Balance, December 31, 2023 | 9003774 | 900 | 3500000 | 350 | 200183 | 20 | 2535090 | (5243689) | (2707329) |
| Net loss | - | - | - | - | - | - | - | (37024) | (37024) |
| Balance, March 31, 2024 | 9003774 | 900 | 3500000 | 350 | 200183 | 20 | 2535090 | (5280713) | (2744353) |
| Return of shares issued for asset purchase agreement | (9000000) | (900) |  |  |  |  | 900 |  |  |
| Shares issued for services | 9000000 | 900 |  |  |  |  | 719100 |  | 720000 |
| Net loss | - | - | - | - | - | - | - | (730207) | (730207) |
| Balance, June 30, 2024 | 9003774 | 900 | 3500000 | 350 | 200183 | 20 | 3255090 | (6010920) | (2754560) |

---

See accompanying notes to the consolidated financial statements

---

| |
|:---|
| 6 |
| *[**Table of Contents**](#toc)* |

---

NEURALBASE AI LTD . AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **For the six months ended** | **For the six months ended** |
|  | **June 30,** <br>**2025** | **June 30,** <br>**2024** |
| Cash Flows from Operating Activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(154667) | $(47231) |
| Adjustments to reconcile net loss to net cash provided by operating activities: |  |  |
| Changes in assets and liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | (679) | 7391 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities - related party | - | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in operating activities | (155346) | (39840) |
| Cash Flows from Financing Activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from notes payable | 59446 | 39840 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in financing activities | 59446 | 39840 |
| Net increase in cash | (95900) | - |
| Cash, beginning of period | - | - |
| Cash, end of period | $(95900) | $- |
| Supplemental disclosure of cash flow information |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for interest | $- | $- |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for taxes | $- | $- |
| **SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares issued for asset purchase agreement | $- | $- |

---

See accompanying notes to the consolidated financial statements

---

| |
|:---|
| 7 |
| *[**Table of Contents**](#toc)* |

---

**NEURALBASE AI LTD** 

**(FKA VIRATECH CORP.)**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**June 30, 2025** 

**NOTE 1 – NATURE OF BUSINESS AND OPERATIONS**

**Organization**

NEURALBASE AI LTD. AND SUBSIDIARIES (formerly known as Viratech Corp, Imperia Entertainment, Soleil Film and Television, Inc. Ameridream Entertainment, Inc. and Mc Smoothie's, Inc. (the Company) was incorporated under the laws of the state of California as Acquisition Solutions on March 21, 2000. It became a Nevada corporation on July 18, 2006.

On March 7, 2023, the Company received notice of resignation from Mr. Henry Chang Manayan ("Mr. Manayan") sole-officer and director of the Company (the "Resignation"), Mr. Manayan stated that his resignation was not the result of any disagreements between himself and the Company relating to the Company's operations, policies, or practices. Effective immediately upon the resignation of Mr. Manayan, the Company appointed Mr. Charandeep Gopishetty ("Mr. Gopishetty") to serve as President, Chief Executive Officer, Treasurer, Chief Financial Officer, and Director of the Company to serve until the next annual meeting of the Company or until his respective successor is duly appointed. Mr. Gopishetty accepted the appointments, effective as of March 7, 2023.

On May 16, 2024, the Company, Gopishetty, and Blackwell entered an Unwind Agreement and Mutual Release (the "Unwind Agreement"), for the purpose of unwinding, and rendering void, the Purchase Agreement ("Original APA") executed by and between the Company, Gopishetty, and Blackwell. The Parties have mutually and voluntarily agreed to unwind the transaction contemplated by the Original APA. Accordingly, the Company shall return all the Assets acquired pursuant to the terms and conditions of the Original APA once Gopishetty has cancelled, and returned to the Company's treasury, the 9,000,000 restricted shares of the Company's Series A Preferred Stock received per the terms of the Original APA. Each of Company, Gopishetty, and Blackwell have made other representations as part of the Unwind Agreement.

Concurrently with the execution of the Unwind Agreement, on May 16, 2024, the Company entered into an Asset Purchase Agreement ("Purchase Agreement"), with Mr. Frank Gomez and Grupo FG SAS, which is the alter-ego of Mr. Gomez (the "Seller"). Grupo FG SAS does not currently conduct any business and was formed specifically to hold various proprietary Artificial Intelligence ("AI") assets relating to that certain technology known as "Multidoc AI". Multidoc AI is an artificial intelligence system that allows businesses and organizations to create their own AI assistants capable of resolving queries by extracting information from the universe of documents within the client company itself. Multidoc AI allows organizations to manage their own digital, scanned, or handwritten documents and when a queried, Multidoc AI not only resolves the request but also indicates from which paragraphs and documents it extracted the information to corroborate the answer accuracy (collectively, all assets held by Grupo FG and all related proprietary and non-proprietary technology, know-how, and all other facets of Seller's operations are referred to as the "Acquired Assets"). The Company acquired the Acquired Assets in exchange for 9,000,000 restricted shares of the Company's Series A Preferred Stock (the "Shares") to be issued to Seller, or his assigns, concurrently with the closing of the Purchase Agreement. The Shares convert at a ratio of 1-for-50, meaning each share of Series A Preferred Stock converts into 50 shares of Common Stock, and the Shares carry voting rights equal to 500 times the number of shares of Common Stock into which shares of Series A Preferred Stock is then convertible, thus giving Seller voting control of the Company. Additionally, each of the Company and Seller made customary representations, warranties, covenants, and indemnities in connection with the Purchase Agreement.

On May 16, 2024, and in connection with the aforementioned Unwind Agreement, Charandeep Gopishetty resigned as Sole-Officer and Director of the Company. The resignations were not the result of any disagreement with the Company on any matter relating to the Company's operations, policies, or practices.

Effective immediately upon the foregoing resignation, the Corporation appointed Mr. Frank Gomez ("Mr. Gomez") to serve as Sole-Officer and Director of the Corporation to serve until the next annual meeting of the Corporation or until his respective successor is duly appointed. Mr. Gomez accepted the appointments dated even herewith (the "Appointment Date").

---

| |
|:---|
| 8 |
| *[**Table of Contents**](#toc)* |

---

**NOTE 2 – GOING CONCERN**

The accompanying financial statements have been prepared in US dollars and in accordance with accounting principles generally accepted in the United States ("GAAP") on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. During the six months ended June 30, 2025, the Company incurred net loss from operations of $154,667 and accumulated deficits of $4,120,024. These conditions raise substantial doubt about the Company's ability to continue as a going concern.

We are entirely dependent on our ability to attract and receive funding from either the sale of securities or outside sources such as private investment or a strategic partner. We currently have no firm agreements or arrangements with respect to any such financing and there can be no assurance that any needed funds will be available to us on acceptable terms or at all. The inability to obtain sufficient funding of our operations in the future will restrict our ability to grow and reduce our ability to continue to conduct business operations. Our failure to raise additional funds will adversely affect our business, and may require us to suspend our operations, which in turn may result in a loss to the purchasers of our common stock. If we are unable to obtain necessary financing, we will likely be required to curtail our development plans. Any additional equity financing may involve substantial dilution to our then existing stockholders.

**NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

**Principles of consolidation**

The consolidated financial statements include the accounts of Viratech, Corp. and its wholly owned subsidiaries Cambridge Golf, LLC, Body Symphony, LLC, and Medori, LLC. All significant inter-company transactions and balances have been eliminated.

**Use of Estimates**

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates.

**Cash and Cash Equivalents**

For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of six months or less to be cash equivalents to the extent the funds are not being held for investment purposes.

**Intangible assets**

The Company follows Financial Accounting Standard Board's (FASB) Codification Topic 350-10 ("ASC 350-10"), "Intangibles – Goodwill and Other". According to this statement, intangible assets with indefinite lives are no longer subject to amortization, but rather an annual assessment of impairment by applying a fair-value based test. Under ASC 350-10, the carrying value of assets are calculated at the lowest level for which there are identifiable cash flows.

**Stock-based compensation**

The Company follows ASC 718-10, "Stock Compensation", which addresses the accounting for transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus on transactions in which an entity obtains employee services in share-based payment transactions. ASC 718-10 is a revision to SFAS No. 123, "Accounting for Stock-Based Compensation," and supersedes Accounting Principles Board ("APB") Opinion No. 25, "Accounting for Stock Issued to Employees," and its related implementation guidance. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized.

---

| |
|:---|
| 9 |
| *[**Table of Contents**](#toc)* |

---

**Concentration of Credit Risk**

The Company has no off-balance-sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign hedging arrangements. The Company maintains all of its cash balances with two financial institutions in the form of demand deposits.

**Loss per Share**

The Company follows ASC Topic 260 to account for the earnings per share. Basic earnings per common share ("EPS") calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation.

**Revenue Recognition**

The Company recognizes revenue from its contracts with customers in accordance with *ASC 606 – Revenue from Contracts with Customers.* The Company recognizes revenues when satisfying the performance obligation of the associated contract that reflects the consideration expected to be received based on the terms of the contract.

Revenue related to contracts with customers is evaluated utilizing the following steps: (i) Identify the contract, or contracts, with a customer; (ii) Identify the performance obligations in the contract; (iii) Determine the transaction price; (iv) Allocate the transaction price to the performance obligations in the contract; (v) Recognize revenue when the Company satisfies a performance obligation.

**Fair Value of Financial Instruments**

The Company measures fair value in accordance with ASC 820 - Fair Value Measurements. ASC 820 defines fair value and establishes a three-level valuation hierarchy for disclosures of fair value measurements. ASC 820 establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, ASC 820 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by ASC 820 are:

Level 1 - Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.

Level 2 - Inputs (other than quoted market prices included in Level 1) are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument's anticipated life.

Level 3 - Inputs reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. Valuation of instruments includes unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.

As defined by ASC 820, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale, which was further clarified as the price that would be received to sell an asset or paid to transfer a liability ("an exit price") in an orderly transaction between market participants at the measurement date

The reported fair values for financial instruments that use Level 2 and Level 3 inputs to determine fair value are based on a variety of factors and assumptions. Accordingly, certain fair values may not represent actual values of the Company's financial instruments that could have been realized as of June 30, 2025 and December 31, 2024 or that will be recognized in the future, and do not include expenses that could be incurred in an actual settlement. The carrying amounts of the Company's financial assets and liabilities, such as cash, accounts receivable, receivables from related parties, prepaid expenses and other, accounts payable, accrued liabilities, and related party and third-party notes payables approximate fair value due to their relatively short maturities. The Company's notes payable approximates the fair value of such instrument based upon management's best estimate of terms that would be available to the Company for similar financial arrangements at June 30, 2025 and 2024.

---

| |
|:---|
| 10 |
| *[**Table of Contents**](#toc)* |

---

**Recent Accounting Pronouncements**

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM"), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. This ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. This ASU is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The amendments in this ASU should be applied retrospectively to all prior periods presented in the financial statements. The Company adopted the ASU and determined that its adoption did not have a material impact on the Company's consolidated financial statements and related disclosures. As defined in the ASU, operating segments are components of an enterprise about which discrete financial information is regularly provided to the CODM in making decisions on how to allocate resources and assess performance for the organization. The Company operates and manages its business as one reportable and operating segment. The Company's CODM is the Chief Executive Officer. The Company's CODM reviews consolidated operating results to make decisions about allocating resources and assessing performance for the entire Company.

The Company does not believe that other standards, which have been issued but are not yet effective, will have a significant impact on its financial statements.

**NOTE 4 –PROMISSORY NOTES**

Promissory notes payable as of June 30, 2025 and December 31, 2024 consists of the following:

---

| | |
|:---|:---|
| **June 30, 2025** | **December 31, 2024** |
| 46000 | $46000 |
| 5000 | 5000 |
| 5000 | 5000 |
| 28500 | 28500 |
| 9667 | 9667 |
| 12439 | 12439 |
| 4495 | 4495 |
| 3000 | 3000 |
| 8670 | 8670 |
| 3000 | 3000 |
| 5565 | 5565 |
| 6500 | 6500 |
| 20000 | 20000 |
| 3045 | 3045 |
| 2230 | 2230 |
| 2500 | 2500 |
| 4500 | 4500 |
| 13005 | 13005 |
| 5923 | 5923 |
| 5000 |  |
| 5000 |  |
| 4000 |  |
| 10000 |  |
| 4155 |  |
| 9000 |  |
| 2000 |  |
| 5000 |  |
| 500 |  |
| 5000 |  |
| 9791 | - |
| 248485 | $189039 |

---

---

| |
|:---|
| 11 |
| *[**Table of Contents**](#toc)* |

---

The Company has issued various promissory notes amounting to $48,167 for general operating purposes. The notes carry a various interest rates ranging from 8 -15% and are due on demand.

The Company received approval from the U.S. Small Business Administration to fund the Company's request for a loan under the SBA's Economic Injury Disaster Loan Program (EDIL loan). In connection with the EDIL Loan, the Company has entered into the promissory note in principal amount of $46,000. The EDIL Loan is scheduled to mature on March 2052, has a 3.75% interest rate, and is subject to the terms and conditions applicable to all loans made pursuant to the EDIL loans as administered by the SBA.

During the six months ended June 30, 2025, the Company issued various promissory notes amounting to $59,446 for general operating purposes. The notes carry a interest rate of 10% and are due on demand. As of June 30, 2025 and December 31, 2024, the Company had notes due to this noteholder amounting to $154,318 and $94,872, respectively.

During the six months ended June 30, 2025 and 2024, the Company recorded interest expense of $11,372 and $7,302, respectively.

**NOTE 5 – RELATED PARTY TRANSACTIONS**

The Company has issued a promissory note amounting to $7,000 for general operating purposes to a related party. The note carries a interest rate of 5% and was due on July 14, 2019.

During the six months ended June 30, 2025 and 2024, the Company recorded interest expense of $174 and $175, respectively.

As of \|June 30, 2025 and December 31, 2024, the Company had advances due to related parties of $80,680 and $80,680, respectively. The amounts due bears no interest and are due on demand.

---

| |
|:---|
| 12 |
| *[**Table of Contents**](#toc)* |

---

**NOTE 6 - COMMITMENTS AND CONTINGENCIES**

From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm business. Management is currently not aware of any such legal proceedings or claims that could have, individually or in the aggregate, a material adverse effect on our business, financial condition, or operating results.

**NOTE 7 – STOCKHOLDERS' EQUITY**

As of June 30, 2025 and December 31, 2024, the Company had 59,790,183 and 200,183 shares of common stock issued and outstanding.

As of June 30, 2025 and December 31, 2024, the Company had 8,003,774 and 9,003,774 shares of Class A preferred stock issued and outstanding, respectively.

As of June 30, 2025 and December 31, 2024, the Company had 3,500,000 and 3,500,000 Class B preferred stock issued and outstanding, respectively.

On January 24, 2025, a shareholder converted 1,000,000 shares of the Company's Series A Preferred Stock into 50,000,000 shares of Common Stock.

During the six months ended June 30, 2025, the Company sold 9,590,000 shares of the Company's Common Stock for $95,500 cash.

**NOTE 8 – SUBSEQUENT EVENTS**

In accordance with ASC Topic 855-10, the Company has analyzed its operations subsequent to June 30, 2025 to the date these financial statements were available to be issued and has determined that it does not have any material subsequent events to disclose in these financial statements.

---

| |
|:---|
| 13 |
| *[**Table of Contents**](#toc)* |

---

**Item 2. Management's Discussion and Analysis of Financial Conditions and Results of Operations.**

**FORWARD-LOOKING STATEMENTS**

*The following discussion may contain forward-looking statements regarding the Company, its business prospects and its results of operations that are subject to certain risks and uncertainties posed by many factors and events that could cause the Company's actual business, prospects and results of operations to differ materially from those that may be anticipated by such forward-looking statements. These forward-looking statements reflect our view only as of the date of this report. The Company cannot guarantee future results, levels of activity, performance, or achievement. The Company does not undertake any obligation to update or correct any forward-looking statements.*

**Results of Operations for the Three Months Ended June 30, 2025 and 2024**

***Revenues***

We had no revenue for the three or six months ended June 30, 2025 and 2024

***Operating Expenses***

Operating expenses increased to $126,683 for the three months ended June 30, 2025, from $6,275 for the same period ended June 30, 2024. Operating expenses increased to $143,121 for the six months ended June 30, 2025, from $39,755 for the same period ended June 30, 2024. The increase in operating expenses is mainly the result of the increase in wages paid to our former CEO.

We expect our operating expenses will increase in the future as the Company begins to generate more licensing revenue.

***Other Expense***

We had other expense of $6,587 for the three months ended June 30, 2025, as compared with other expenses of $723,932 for the three months ended June 30, 2024. We had other expense of $11,546 for the six months ended June 30, 2025, as compared with other expenses of $727,476 for the six months ended June 30, 2024. The decrease in other expenses is mainly the result of the a loss on acquisition of intangible assets incurred during the three and six month ended June 30, 2024.

***Net Loss***

We recorded a net loss of $133,270 for the three months ended June 30, 2025, as compared with a net loss of $730,207 for the three months ended June 30, 2024. We recorded a net loss of $154,667 for the six months ended June 30, 2025, as compared with a net loss of $767,231 for the six months ended June 30, 2024.

**Liquidity and Capital Resources**

**Going concern** – The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred cumulative net losses of $40,501,574 since its inception and requires capital for its contemplated operational and marketing activities to take place. The Company's ability to generate the necessary funds through licensing of its core products or the ability to raise additional capital through the future issuances of common stock or debt is unknown. The obtainment of additional financing, the successful development of the Company's contemplated plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. These factors, among others, raises substantial doubt about the Company's ability to continue as a going concern. The condensed consolidated financial statements of the Company do not include any adjustments that may result from the outcome of these aforementioned uncertainties.

---

| |
|:---|
| 14 |
| *[**Table of Contents**](#toc)* |

---

As of June 30, 2025, we had total assets in the amount of $0. Our total current liabilities as of June 30, 2025 were $767,764. We had a working capital deficit of $767,764 as of June 30, 2025, compared with a working capital deficit of $708,997 as of December 31, 2024.

Operating activities used $153,346 in cash for the six months ended June 30, 2025, as compared with $39,840 used for the six months ended June 30, 2024. Our negative operating cash flows for 2024 and 2025 were largely the result of our net loss for those quarters, mainly offset by changes in operating assets and liabilities and the amortization of debt discount and amortization.

Cash flow provided from financing activities was $59,446 for the six months ended June 30, 2025, as compared with $39,840 provided by cash flows for financing activities during the six months ended June 30, 2024. Our debt from financing activities consist the issuance of notes payable.

Based upon our current financial condition, we do not have sufficient cash to operate our business at the current level for the next twelve months. We intend to fund operations through increased sales and debt and/or equity financing arrangements, which may be insufficient to fund expenditures or other cash requirements. We plan to seek additional financing in a private equity offering to secure funding for operations. There can be no assurance that we will be successful in raising additional capital.

**Off Balance Sheet Arrangements**

As of June 30, 2025, there were no off-balance sheet arrangements.

---

| |
|:---|
| 15 |
| *[**Table of Contents**](#toc)* |

---

**Item 3. Quantitative and Qualitative Disclosures about Market Risk**

As a smaller reporting company, we are not required to provide the information required by this Item.

**ITEM 4. CONTROLS AND PROCEDURES**

**Management's Responsibility for Controls and Procedures**

The Company's management is responsible for establishing and maintaining adequate internal control over the Company's financial reporting. The Company's controls over financial reporting are designed under the supervision of the Company's Principal Executive Officer and Principal Financial Officer to ensure that information required to be disclosed by the Company in the reports that the Company files or submits under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is accumulated and communicated to the Company's management, including the Company's principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

**Evaluation of Disclosure Controls and Procedures**

Under the supervision and with the participation of our Principal Executive Officer and Chief Financial Officer, the Company conducted an evaluation of the effectiveness of the design and operation of its disclosure controls and procedures, as such term is defined under Rule 13a-15(e) promulgated under the Exchange Act, as of June 30, 2025. Based on this evaluation, management concluded that our financial disclosure controls and procedures were not effective so as to timely record, process, summarize and report financial information required to be included on our SEC reports due to the Company's limited internal resources and lack of ability to have multiple levels of transaction review. However, as a result of our evaluation and review process, management believes that the financial statements and other information presented herewith are materially correct.

**Internal Control Over Financial Reporting**

As of June 30, 2025, under the supervision and with the participation of our management, we conducted an evaluation of the effectiveness of the design and operations of our internal control over financial reporting, as defined in Rules 13a-15(f) or 15d-15(f) promulgated under the Securities Exchange Act of 1934 and based on the criteria for effective internal control described in *Internal Control – Integrated Framework* issued by the Committee of Sponsoring Organizations of the Treadway Commission (as revised). Based on our evaluation, management concluded that our internal control over financial reporting was not effective so as to timely record, process, summarize and report financial information required to be included on our Securities and Exchange Commission ("SEC") reports due to the Company's limited internal resources and lack of ability to have multiple levels of transaction review. However, as a result of our evaluation and review process, management believes that the financial statements and other information presented herewith are materially correct.

The management including its Principal Executive Officer/Principal Financial Officer, does not expect that its disclosure controls and procedures, or its internal controls over financial reporting will prevent all error and all fraud. A control system no matter how well conceived and operated, can provide only reasonable not absolute assurance that the objectives of the control system are met. Further, the design of the control system must reflect the fact that there are resource constraints, and the benefit of controls must be considered relative to their costs.

Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.

---

| |
|:---|
| 16 |
| *[**Table of Contents**](#toc)* |

---

The Company has limited resources and as a result, a material weakness in financial reporting currently exists, because of our limited resources and personnel, including those described below.

\* The Company has an insufficient quantity of dedicated resources and experienced personnel involved in reviewing and designing internal controls. As a result, a material misstatement of the interim and annual financial statements could occur and not be prevented or detected on a timely basis.

\* We have not achieved the optimal level of segregation of duties relative to key financial reporting functions.

\* We do not have an audit committee or an independent audit committee financial expert. While not being legally obligated to have an audit committee or independent audit committee financial expert, it is management's view that to have an audit committee, comprised of independent board members, and an independent audit committee financial expert is an important entity-level control over the Company's financial statements.

A material weakness is a deficiency (within the meaning of the Public Company Accounting Oversight Board (PCAOB) auditing standard 5) or combination of deficiencies in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the Company's annual or interim financial statements will not be prevented or detected on a timely basis. Management has determined that a material weakness exists due to a lack of segregation of duties, resulting from the Company's limited resources and personnel.

**Remediation Efforts to Address Deficiencies in Internal Control Over Financial Reporting**

As a result of these findings, management, upon obtaining sufficient capital and operations, intends to take practical, cost-effective steps in implementing internal controls, including the possible remedial measures set forth below. As of June 30, 2025, we did not have sufficient capital and/or operations to implement any of the remedial measures described below.

\* Assessing the current duties of existing personnel and consultants, assigning additional duties to existing personnel and consultants, and, in a cost effective manner, potentially hiring additional personnel to assist with the preparation of the Company's financial statements to allow for proper segregation of duties, as well as additional resources for control documentation.

\* Assessing the duties of the existing officers of the Company and, in a cost effective manner, possibly promote or hire additional personnel to diversify duties and responsibilities of such executive officers.

\* Board to review and make recommendations to shareholders concerning the composition of the Board of Directors, with particular focus on issues of independence. The Board of Directors will consider nominating an audit committee and audit committee financial expert, which may or may not consist of independent members.

\* Interviewing and potentially hiring outside consultants that are experts in designing internal controls over financial reporting based on criteria established in Internal Control Integrated Framework issued by Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO") (as revised).

**(b) Change in Internal Control Over Financial Reporting**

The Company has not made any change in our internal control over financial reporting during the period ended June 30, 2025.

---

| |
|:---|
| 17 |
| *[**Table of Contents**](#toc)* |

---

**PART II. OTHER INFORMATION**

**Item 1. Legal Proceedings.**

We are not party to any material legal proceedings. From time to time, we may be involved in legal proceedings or subject to claims incident to the ordinary course of business. The outcome of litigation is inherently uncertain, and there can be no assurances that favorable outcomes will be obtained. In addition, regardless of the outcome, such proceedings or claims can have an adverse impact on us, which may be material because of defense and settlement costs, diversion of resources and other factors.

**Item 1A. Risk Factors.** 

The risks described under the heading "Risk Factors" in our Factors that could cause or contribute to such differences may include, but are not limited to, those described under the heading *"Risk Factors"* which are included in the Company's Registration Statement on Form 10, as amended, which was previously filed with the Securities and Exchange Commission. The risks and uncertainties described therein are not the only ones we face. Additional risks and uncertainties that we are unaware of or that we currently deem immaterial may also become important factors that adversely affect our business.

You should carefully read and consider such risks, together with all of the other information in our Registration Statement on Form 10 and in this Quarterly Report on Form 10-Q (including the disclosures in the section titled "Management's Discussion and Analysis of Financial Condition and Results of Operations" and in our condensed consolidated financial statements and related notes), and in the other documents that we file with the SEC.

There have been no material changes from the risk factors previously disclosed under the heading "Risk Factors" in our Registration Statement on Form 10, as amended.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) During the quarter ended June 30, 2025, there were no unregistered sales of our securities that were not reported in a Current Report on Form 8-K, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Not applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) None.

**Item 3. Defaults Upon Senior Securities.**

None.

**Item 4. Mine Safety Disclosures.**

Not Applicable.

**Item 5. Other Information.**

None

---

| |
|:---|
| 18 |
| *[**Table of Contents**](#toc)* |

---

**ITEM 6 - EXHIBITS**

---

| | |
|:---|:---|
| **Exhibit No.**  | **Document Description** |
| [3.1](http://www.sec.gov/Archives/edgar/data/1130781/000147793224004395/mblc_ex31.htm) | [Amended and Restated Articles of Incorporation (1)](http://www.sec.gov/Archives/edgar/data/1130781/000147793224004395/mblc_ex31.htm) |
| [3.2](http://www.sec.gov/Archives/edgar/data/1130781/000147793224004981/vira_ex31.htm) | [Certificate of Amendment filed with the Nevada Secretary of State (2)](http://www.sec.gov/Archives/edgar/data/1130781/000147793224004981/vira_ex31.htm) |
| [3.3](http://www.sec.gov/Archives/edgar/data/1130781/000147793224004981/vira_ex32.htm) | [Certificate of Change Pursuant to NRS 78.209 citing Reverse Stock Split (2)](http://www.sec.gov/Archives/edgar/data/1130781/000147793224004981/vira_ex32.htm) |
| [3.4](http://www.sec.gov/Archives/edgar/data/1130781/000147793224004395/mblc_ex32.htm) | [Bylaws (1)](http://www.sec.gov/Archives/edgar/data/1130781/000147793224004395/mblc_ex32.htm) |
| [31.1](nbbi_ex311.htm) | [Certification of Chief Executive Officer and Chief Financial Officer](nbbi_ex311.htm) |
| [32.1](nbbi_ex321.htm) | [Certifications of Chief Executive Officer and Chief Financial Officer](nbbi_ex321.htm) |
| 101.INS | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |

---

____________

*(1)Filed as Exhibits to the Company's Registration Statement on Form 10-12G originally Filed with the Commission on July 26, 2024*

*(2)Filed as an Exhibit to the Company's Current Report on Form 8-K filed with the Commission on August 16, 2024*

---

| |
|:---|
| 19 |
| *[**Table of Contents**](#toc)* |

---

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Neuralbase AI Ltd.** | **Neuralbase AI Ltd.** |
| Date: August 14, 2025 | By: | */s/ Vighnesh Dobale* |
|  | Name: | Vighnesh Dobale |
|  | Title: | Chief Executive Officer & Chief Financial Officer |

---

## Exhibit 31.1

**EXHIBIT 31.1**

**CERTIFICATION**

I, **Frank Gomez**, Chief Executive Officer and Chief Financial Officer of **Neuralbase AI Ltd. (the "Registrant")**, certify that:

1. I have reviewed this Quarterly Report on **Form 10-Q** of the Registrant for the fiscal quarter ended June 30, 2025;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

---

| |
|:---|
| Dated: August 14, 2025 |
| */s/ Frank Gomez* |
| Chief Executive Officer and Chief Financial Officer<br> (Principal executive, financial and accounting officer) |

---

## Exhibit 32.1

**EXHIBIT 32.1**

**CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of **Neuralbase AI Ltd.** (the "Company") on Form 10-Q for the period ending June 30, 2025, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, **Frank Gomez**, Chief Executive Officer and Chief Financial Officer of **Neuralbase AI Ltd.,** certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

---

| | |
|:---|:---|
| August 14, 2025 | */s/ Frank Gomez* |
|  | Chief Executive Officer and Chief Financial Officer<br> (Principal executive, financial and accounting officer) |

---